The Effects of Polyunsaturated Fatty Acids (PUFA) on Allergic/Atopic Dermatitis
NCT ID: NCT01936194
Last Updated: 2016-09-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2013-09-30
2014-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Nutritional Study to Determine the Effect of Fish Oil on Atopic Dermatitis
NCT06194045
Does Omega-3 Fatty Acid Supplementation in Pregnancy and During Lactation Protect the Child From Allergic Disease?
NCT00892684
Fish Oil Supplementation During Pregnancy for Prevention of Asthma, Eczema and Allergies in Childhood
NCT00798226
Early DHA Supplementation in Very Low Birth Weight Infants
NCT03192839
Effect of Docosahexaenoic Acid (DHA)-Enriched Human Milk in Premature Newborns
NCT01062373
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Docosahexaenoic Acid (DHA)
infants receiving capsule containing DHA.
DHA
High Olive Oil
infants receiving capsule without DHA and EPA.
High Olive Oil
DHA+EPA
infants receiving capsule containing DHA and EPA.
DHA+EPA
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
DHA+EPA
High Olive Oil
DHA
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Mother delivers after 36 weeks
* Mother is willing to breast-feed for four months
* Mother has potential to deliver a child with increased risk of atopic dermatitis
* Signed Informed Consent
Exclusion Criteria
* Disease with influence on breast feeding
* Complicated pregnancy
* Allergic to seafood
* Allergic to soy
* Allergic to marine fish
* Mother has more than two salmon or tuna meals per week
* Mother is undergoing treatment with anticoagulants
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
International Peace Maternity and Child Health Hospital
OTHER
Chinese Academy of Sciences
OTHER_GOV
Mead Johnson Nutrition
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Zhiwei Liu, M.D.
Role: PRINCIPAL_INVESTIGATOR
International Peace Maternity and Child Health Hospital of China Welfare Institution
Huiyong Yin, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Chinese Academy of Sciences
Bryan Liu, Ph.D.
Role: STUDY_DIRECTOR
Mead Johnson & Company
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
International Peace Maternity and Child Health Hospital of China welfare Institute
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
6018
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.